We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,069 results
  1. Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

    Computational drug repurposing aims to identify new indications for existing drugs by utilizing high-throughput data, often in the form of biomedical...

    Dongmin Bang, Sangsoo Lim, ... Sun Kim in Nature Communications
    Article Open access 15 June 2023
  2. Single-cell-led drug repurposing for Alzheimer’s disease

    Alzheimer’s disease is the most common form of dementia. Notwithstanding the huge investments in drug development, only one disease-modifying...

    Silvia Parolo, Federica Mariotti, ... Enrico Domenici in Scientific Reports
    Article Open access 05 January 2023
  3. Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor

    Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infection in infants, older adults and the immunocompromised....

    Svenja M. Sake, **aoyu Zhang, ... Thomas Pietschmann in Nature Communications
    Article Open access 08 February 2024
  4. Identification of potential new COVID-19 treatments via RWD-driven drug repurposing

    By utilizing Optum Life Sciences Claims Data, we constructed Real World Data (RWD) cohorts comprising over 3 million patients and simulated a...

    Yun Liao in Scientific Reports
    Article Open access 04 September 2023
  5. Conformational diversity and protein–protein interfaces in drug repurposing in Ras signaling pathway

    We focus on drug repurposing in the Ras signaling pathway, considering structural similarities of protein–protein interfaces. The interfaces formed...

    Ahenk Zeynep Sayin, Zeynep Abali, ... Ozlem Keskin in Scientific Reports
    Article Open access 12 January 2024
  6. Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

    Bruton's tyrosine kinase (BTK) is a non-receptor protein kinase that plays a crucial role in various biological processes, including immune system...

    Mohammed Alrouji, Lizy Sonia Benjamin, ... Atiya Akhtar in Scientific Reports
    Article Open access 17 October 2023
  7. Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding

    The search for an effective drug is still urgent for COVID-19 as no drug with proven clinical efficacy is available. Finding the new purpose of an...

    Md Kamrul Islam, Diego Amaya-Ramirez, ... Malika Smaïl-Tabbone in Scientific Reports
    Article Open access 04 March 2023
  8. The OREGANO knowledge graph for computational drug repurposing

    Drug repositioning is a faster and more affordable solution than traditional drug discovery approaches. From this perspective, computational drug...

    Marina Boudin, Gayo Diallo, ... Fleur Mougin in Scientific Data
    Article Open access 06 December 2023
  9. Metabolic modeling-based drug repurposing in Glioblastoma

    The manifestation of intra- and inter-tumor heterogeneity hinders the development of ubiquitous cancer treatments, thus requiring a tailored therapy...

    Claudio Tomi-Andrino, Alina Pandele, ... Dong-Hyun Kim in Scientific Reports
    Article Open access 01 July 2022
  10. One of the 5-aminosalicylates drug, mesalamine as a drug repurposing lead against breast cancer

    Background

    Breast cancer is the world's second leading cause of death in women. The problem of chemoresistance in breast cancer is proving to be a...

    Dayanand Swami, Shafina Siddiqui, ... Jyotirmoi Aich in Bulletin of the National Research Centre
    Article Open access 26 September 2022
  11. In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches

    The pandemic of coronavirus disease 2019 (COVID-19) caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...

    Chunye Zhang, Jiazheng Liu, ... Ming Yang in Scientific Reports
    Article Open access 04 December 2023
  12. Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion

    Neuroblastoma, the most common type of pediatric extracranial solid tumor, causes 10% of childhood cancer deaths. Despite intensive multimodal...

    Annie Beaudry, Simon Jacques-Ricard, ... Noël J.-M. Raynal in Scientific Reports
    Article Open access 30 September 2023
  13. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus

    Monkeypox viral infection is an emerging threat and a major concern for the human population. The lack of drug molecules to treat this disease may...

    Thamir A. Alandijany, Mai M. El-Daly, ... Esam I. Azhar in Scientific Reports
    Article Open access 04 September 2023
  14. Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes

    The COVID-19 pandemic caused by the SARS-CoV-2 virus has greatly affected global health. Emerging evidence suggests a complex interplay between...

    Dicson Sheeja Malar, Kanika Verma, ... James Michael Brimson in Scientific Reports
    Article Open access 21 February 2024
  15. Exploring the pathways of drug repurposing and Panax ginseng treatment mechanisms in chronic heart failure: a disease module analysis perspective

    Chronic Heart Failure (CHF) is a significant global public health issue, with high mortality and morbidity rates and associated costs. Disease...

    Chengzhi **e, Ying Zhang, ... Na Lang in Scientific Reports
    Article Open access 27 May 2024
  16. Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

    Discovering novel uses for existing drugs, through drug repurposing, can reduce the time, costs, and risk of failure associated with new drug...

    Patrick Wu, Qi** Feng, ... Wei-Qi Wei in Nature Communications
    Article Open access 10 January 2022
  17. Drug repurposing: a nexus of innovation, science, and potential

    Maria Cristina De Rosa, Rituraj Purohit, Alfonso T. García-Sosa in Scientific Reports
    Article Open access 19 October 2023
  18. Network controllability solutions for computational drug repurposing using genetic algorithms

    Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key...

    Victor-Bogdan Popescu, Krishna Kanhaiya, ... Ion Petre in Scientific Reports
    Article Open access 26 January 2022
  19. Network medicine for disease module identification and drug repurposing with the NeDRex platform

    Traditional drug discovery faces a severe efficacy crisis. Repurposing of registered drugs provides an alternative with lower costs and faster drug...

    Sepideh Sadegh, James Skelton, ... Tim Kacprowski in Nature Communications
    Article Open access 25 November 2021
  20. ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs

    Single-cell RNA sequencing technology has enabled in-depth analysis of intercellular heterogeneity in various diseases. However, its full potential...

    Bing He, Yao **ao, ... Lana X. Garmire in Nature Communications
    Article Open access 22 February 2023
Did you find what you were looking for? Share feedback.